Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.65 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.65 |
| ▸ | ALDH1A3 | P47895 | 5/20 | 0.53 |
| ▸ | TERT | O14746 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | S100B | P04271 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29663202 | 1.00 | ALDH1A1 (0.68) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL24988105 | 0.98 | TRIM24 (0.67) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL30343620 | 0.98 | TRIM24 (0.67) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL24989604 | 0.95 | TRIM24 (0.61) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL30343617 | 0.95 | TRIM24 (0.61) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL2013869 | 0.83 | ALDH1A1 (0.70) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL31611878 | 0.83 | HTR3E (0.63) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL1688379 | 0.83 | ALDH3A1 (0.56) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL160596 | 0.81 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 | |
| SCHEMBL896372 | 0.81 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2KDM4ETRIM24TRIM33 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652155-A1 | AMYLOID TARGETING AGENTS | Amydis, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12478693-B2 | Compositions and methods for detection of traumatic brain injury | Amydis, Inc. (US) | 2025-11-25 | — | — | US | disclosed |
| US-20250282723-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-11 | — | — | US | disclosed |
| US-20250213732-A1 | PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS | AMYDIS INC (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4545518-A2 | PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS | Amydis, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20240325572-A1 | N-HETEROCYCLYL SUBSTITUTED 2-CYANO-3-(NAPHTHALEN-2-YL)ACRYLAMIDE DERIVATIVES AS FLUOROPHORS FOR DETECTION OF AMYLOID AND AMYLOID-LIKE PROTEINS FOR DIAGNOSIS OF NEURODEGENERATIVE DISORDERS | Amydis, Inc. | 2024-10-03 | — | — | US | disclosed |
| WO-2024155678-A1 | AMYLOID TARGETING AGENTS | Amydis, Inc. (US) | 2024-07-25 | — | — | WO | disclosed |
| EP-3873466-B1 | PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS | AMYDIS INC (US) | 2024-07-24 | — | — | EP | disclosed |
| US-20240208916-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | Amydis, Inc. | 2024-06-27 | — | — | US | disclosed |
| US-20240208916-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | Amydis, Inc. | 2024-06-27 | — | — | US | disclosed |
| EP-3062150-A2 | CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015143185-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | AMYDIS DIAGNOSTICS (US) | 2015-09-24 | — | — | WO | disclosed |
| WO-2015143185-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | AMYDIS DIAGNOSTICS (US) | 2015-09-24 | — | — | WO | disclosed |
| US-20150177262-A1 | AMYLOID BINDING AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-06-25 | — | — | US | disclosed |
| EP-2509940-B1 | AMYLOID BINDING AGENTS | UNIV CALIFORNIA (US) | 2015-06-10 | — | — | EP | disclosed |
| US-8940918-B2 | Amyloid binding agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-01-27 | — | — | US | disclosed |
| US-20120302603-A1 | AMYLOID BINDING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-11-29 | — | — | US | disclosed |
| EP-2509940-A2 | AMYLOID BINDING AGENTS | The Regents of the University of California (US) | 2012-10-17 | — | — | EP | disclosed |
| US-20120088746-A1 | AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | PFIZER INC. (US) | 2012-04-12 | — | — | US | disclosed |
| WO-2011072257-A2 | AMYLOID BINDING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302603-A1 | AMYLOID BINDING AGENTS | APP, APBA1, PSEN1 | ALDH1A1 3897/4885SMN1; SMN2 355/4885KDM4E 4814/4885 |
| US-20240208916-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | APP, CRYAA, APBA1 | ALDH1A1 4151/4885SMN1; SMN2 1194/4885KDM4E 4807/4885 |
| US-12478693-B2 | Compositions and methods for detection of traumatic brain injury | S100B, FABP7, CRYAB | ALDH1A1 4102/4885SMN1; SMN2 1319/4885KDM4E 4796/4885 |
| US-20250282723-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | CRYAA, IAPP, APP | ALDH1A1 4174/4885SMN1; SMN2 964/4885KDM4E 4812/4885 |
| US-20120088746-A1 | AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | TRPV1, TRPA1, TRPV2 | ALDH1A1 1265/4885SMN1; SMN2 2207/4885KDM4E 4075/4885 |
| US-20250213732-A1 | PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS | PYGB, PSEN2, PSEN1 | ALDH1A1 4527/4885SMN1; SMN2 86/4885KDM4E 4579/4885 |
| US-20240325572-A1 | N-HETEROCYCLYL SUBSTITUTED 2-CYANO-3-(NAPHTHALEN-2-YL)ACRYLAMIDE DERIVATIVES AS FLUOROPHORS FOR DETECTION OF AMYLOID AND AMYLOID-LIKE PROTEINS FOR DIAGNOSIS OF NEURODEGENERATIVE DISORDERS | TARDBP, CDR2, NLN | ALDH1A1 2727/4885SMN1; SMN2 305/4885KDM4E 4591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.